These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 34170908)

  • 21. In chronic heart failure with marked fluid retention, the i.v. high doses of loop diuretic are a predictor of aggravated renal dysfunction, especially in the set of heart failure with normal or only mildly impaired left ventricular systolic function.
    De Vecchis R; Ciccarelli A; Ariano C; Cioppa C; Giasi A; Pucciarelli A; Cantatrione S
    Minerva Cardioangiol; 2011 Dec; 59(6):543-54. PubMed ID: 21330961
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Loop diuretic strategies in patients with acute decompensated heart failure: a meta-analysis of randomized controlled trials.
    Wu MY; Chang NC; Su CL; Hsu YH; Chen TW; Lin YF; Wu CH; Tam KW
    J Crit Care; 2014 Feb; 29(1):2-9. PubMed ID: 24331943
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Outpatient treatment of worsening heart failure with intravenous and subcutaneous diuretics: a systematic review of the literature.
    Wierda E; Dickhoff C; Handoko ML; Oosterom L; Kok WE; de Rover Y; de Mol BAJM; van Heerebeek L; Schroeder-Tanka JM
    ESC Heart Fail; 2020 Jun; 7(3):892-902. PubMed ID: 32159279
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of adding nitroglycerin to early diuretic therapy on the morbidity and mortality of patients with chronic kidney disease presenting with acute decompensated heart failure.
    Aziz EF; Kukin M; Javed F; Pratap B; Sabharwal MS; Tormey D; Frankenberger O; Herzog E
    Hosp Pract (1995); 2011 Feb; 39(1):126-32. PubMed ID: 21441767
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Short-term diuretic withdrawal in stable outpatients with mild heart failure and no fluid retention receiving optimal therapy: a double-blind, multicentre, randomized trial.
    Rohde LE; Rover MM; Figueiredo Neto JA; Danzmann LC; Bertoldi EG; Simões MV; Silvestre OM; Ribeiro ALP; Moura LZ; Beck-da-Silva L; Prado D; Sant'Anna RT; Bridi LH; Zimerman A; Raupp da Rosa P; Biolo A
    Eur Heart J; 2019 Nov; 40(44):3605-3612. PubMed ID: 31424503
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Early diuretic strategies and the association with In-hospital and Post-discharge outcomes in acute heart failure.
    Fudim M; Spates T; Sun JL; Kittipibul V; Testani JM; Starling RC; Tang WHW; Hernandez AF; Felker GM; O'Connor CM; Mentz RJ
    Am Heart J; 2021 Sep; 239():110-119. PubMed ID: 34052212
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of Ambulatory, High-Dose, Intravenous Diuretic Therapy to Standard Hospitalization and Diuretic Therapy for Treatment of Acute Decompensated Heart Failure.
    Buckley LF; Seoane-Vazquez E; Cheng JW; Aldemerdash A; Cooper IM; Matta L; Medina DS; Mehra MR; Navarro-Velez K; Shea EL; Weintraub JR; Stevenson LW; Desai AS
    Am J Cardiol; 2016 Nov; 118(9):1350-1355. PubMed ID: 27772698
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intravenous salt supplementation with low-dose furosemide for treatment of acute decompensated heart failure.
    Okuhara Y; Hirotani S; Naito Y; Nakabo A; Iwasaku T; Eguchi A; Morisawa D; Ando T; Sawada H; Manabe E; Masuyama T
    J Card Fail; 2014 May; 20(5):295-301. PubMed ID: 24462960
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Spot urine sodium excretion as prognostic marker in acutely decompensated heart failure: the spironolactone effect.
    Ferreira JP; Girerd N; Medeiros PB; Santos M; Carvalho HC; Bettencourt P; Kénizou D; Butler J; Zannad F; Rossignol P
    Clin Res Cardiol; 2016 Jun; 105(6):489-507. PubMed ID: 26615605
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diuretic dosing in acute decompensated heart failure: lessons from DOSE.
    Campbell PT; Ryan J
    Curr Heart Fail Rep; 2012 Sep; 9(3):260-5. PubMed ID: 22699924
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diuretic Strategies for Loop Diuretic Resistance in Acute Heart Failure: The 3T Trial.
    Cox ZL; Hung R; Lenihan DJ; Testani JM
    JACC Heart Fail; 2020 Mar; 8(3):157-168. PubMed ID: 31838029
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A prospective, randomized study to evaluate the efficacy of various diuretic strategies in acute decompensated heart failure.
    Shah RA; Subban V; Lakshmanan A; Narayanan S; Udhayakumaran K; Pakshirajan B; Krishnamoorthy J; Latchumanadhas K; Janakiraman E; Mullasari AS
    Indian Heart J; 2014; 66(3):309-16. PubMed ID: 24973836
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Troponin I release after intravenous treatment with high furosemide doses plus hypertonic saline solution in decompensated heart failure trial (Tra-HSS-Fur).
    Parrinello G; Di Pasquale P; Torres D; Cardillo M; Schimmenti C; Lupo U; Iatrino R; Petrantoni R; Montaina C; Giambanco S; Paterna S
    Am Heart J; 2012 Sep; 164(3):351-7. PubMed ID: 22980301
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Continuous versus bolus dosing of Furosemide for patients hospitalized for heart failure.
    Allen LA; Turer AT; Dewald T; Stough WG; Cotter G; O'Connor CM
    Am J Cardiol; 2010 Jun; 105(12):1794-7. PubMed ID: 20538132
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rationale and Design of the "Safety and Efficacy of the Combination of Loop with Thiazide-type Diuretics in Patients with Decompensated Heart Failure (CLOROTIC) Trial:" A Double-Blind, Randomized, Placebo-Controlled Study to Determine the Effect of Combined Diuretic Therapy (Loop Diuretics With Thiazide-Type Diuretics) Among Patients With Decompensated Heart Failure.
    Trullàs JC; Morales-Rull JL; Casado J; Freitas Ramírez A; Manzano L; Formiga F;
    J Card Fail; 2016 Jul; 22(7):529-36. PubMed ID: 26576715
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Outpatient intravenous diuretic therapy; potential for marked reduction in hospitalisations for acute decompensated heart failure.
    Ryder M; Murphy NF; McCaffrey D; O'Loughlin C; Ledwidge M; McDonald K
    Eur J Heart Fail; 2008 Mar; 10(3):267-72. PubMed ID: 18308632
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of admission oral diuretic dose on response to continuous versus bolus intravenous diuretics in acute heart failure: an analysis from diuretic optimization strategies in acute heart failure.
    Shah RV; McNulty S; O'Connor CM; Felker GM; Braunwald E; Givertz MM
    Am Heart J; 2012 Dec; 164(6):862-8. PubMed ID: 23194486
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy and Safety of Intravenous Chlorothiazide versus Oral Metolazone in Patients with Acute Decompensated Heart Failure and Loop Diuretic Resistance.
    Shulenberger CE; Jiang A; Devabhakthuni S; Ivaturi V; Liu T; Reed BN
    Pharmacotherapy; 2016 Aug; 36(8):852-60. PubMed ID: 27393709
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of metolazone versus chlorothiazide in acute decompensated heart failure with diuretic resistance.
    Moranville MP; Choi S; Hogg J; Anderson AS; Rich JD
    Cardiovasc Ther; 2015 Apr; 33(2):42-9. PubMed ID: 25712736
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluating the safety and efficacy of sodium-restricted/Dietary Approaches to Stop Hypertension diet after acute decompensated heart failure hospitalization: design and rationale for the Geriatric OUt of hospital Randomized MEal Trial in Heart Failure (GOURMET-HF).
    Wessler JD; Maurer MS; Hummel SL
    Am Heart J; 2015 Mar; 169(3):342-348.e4. PubMed ID: 25728723
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.